Laurent Chouchana

InstitutionCentre régional de pharmacovigilance Paris-Cochin
AddressFrance
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 4 publications in February 2021
    All Publications
    Bar chart showing 19 publications over 10 distinct years, with a maximum of 7 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chouchana L, Canouï E, Batista R, Contejean A, Cariou A, Treluyer JM, Charlier C. Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers. Therapie. 2021 Jul 27. PMID: 34462137.
      Citations:    Fields:    
    2. Chouchana L, Beeker N, Garcelon N, Rance B, Paris N, Salamanca E, Polard E, Burgun A, Treluyer JM, Neuraz A. Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19. Cardiovasc Drugs Ther. 2021 Mar 04. PMID: 33661434.
      Citations:    Fields:    
    3. Touafchia A, Bagheri H, Carrié D, Durrieu G, Sommet A, Chouchana L, Montastruc F. Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns. Clin Microbiol Infect. 2021 Feb 27. PMID: 33647441.
      Citations: 13     Fields:    
    4. Chouchana L, Preta LH, Tisseyre M, Terrier B, Treluyer JM, Montastruc F. Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case-noncase study. Kidney Int. 2021 05; 99(5):1235-1236. PMID: 33647327.
      Citations:    Fields:    Translation:Humans
    5. Chouchana L, Beeker N, Garcelon N, Rance B, Paris N, Salamanca E, Polard E, Burgun A, Treluyer JM, Neuraz A. Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19. Cardiovasc Drugs Ther. 2021 Feb 17. PMID: 33595761.
      Citations: 1     Fields:    
    6. Chouchana L, Boujaafar S, Gana I, Preta LH, Regard L, Legendre P, Azoulay C, Canouï E, Zerbit J, Carlier N, Terrier B, Kernéis S, Batista R, Treluyer JM, Zheng Y, Benaboud S. Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients. Ther Drug Monit. 2021 02 01; 43(1):131-135. PMID: 33230045.
      Citations:    Fields:    Translation:Humans
    7. Gérard A, Romani S, Fresse A, Viard D, Parassol N, Granvuillemin A, Chouchana L, Rocher F, Drici MD. "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. Therapie. 2020 Jul - Aug; 75(4):371-379. PMID: 32418730.
      Citations: 35     Fields:    Translation:HumansPHPublic Health